Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex

Journal of Molecular Neuroscience

Volumn 9, Issue 3, 1997, Pages 167-176

  Huang, Nuo Yu ^a   Strakhova, Marina ^a,b   Layer, Richard T ^a,c   Skolnick, Phil ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Cognetix Inc ^*  (United States)

Author keywords

Cytochrome b; Differential display PCR; Electroconvulsive shock (ECS); Imipramine

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME B; HALOPERIDOL; IMIPRAMINE; MESSENGER RNA; MORPHINE;

ANIMAL; ARTICLE; BRAIN CORTEX; DRUG ADMINISTRATION; DRUG EFFECT; ELECTRIC SHOCK; GENE EXPRESSION REGULATION; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; CEREBRAL CORTEX; CYTOCHROME B GROUP; DRUG ADMINISTRATION SCHEDULE; ELECTROSHOCK; GENE EXPRESSION REGULATION; HALOPERIDOL; IMIPRAMINE; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MORPHINE; RNA, MESSENGER;

EID: 0031304921     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02800499     Document Type: Article

References (39)

1. Andrews J. M. and Nemeroff C. B. (1994) Contemporary management of depression. Am. J. Med. 97(S 6A), 24S-32S.
2. Bibb M. J., Van Etten R. A., Wright C. T., Walberg M. W., and Clayton D. A. (1981) Sequence and gene organization of mouse mitochondrial DNA. Cell 26, 167-180.
3. Chandrasekaran K., Giordano T., Brady D. R., Stoll J., Martin L. J., and Rapoport S. I. (1994) Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Mol. Brain Res. 24, 336-340.
4. Chomezynski P. and Sacchi N. (1987) Single step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
5. Church G. M. and Gilbert W. (1984) Genomic sequencing. Proc. Natl. Acad. Sci. USA 81, 1991-1995.
6. Crowe R. R. (1984) Electroconvulsive therapy - a current perspective. N. Engl. J. Med. 311, 163-167.
7. Douglass J., McKinzie A. A., and Couceyro P. (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 15, 2471-2481.
8. Drevets W. C., Videen T. O., Price J. L., Preskorn S. H., Carmichael S. T., and Raichle M. E. (1992) A functional anatomical study of unipolar depression. J. Neurosci. 12, 3628-3641.
9. Drevets W. C., Price J. L., Simpson J. R. Jr., Todd R. D., Reich T., Vannier M., et al. (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827.
10. Duman R. S., Nibuya M., and Vaidya V. A. (1997) A role for CREB in antidepressant action, in Antidepressants: New Pharmacological Strategies (Skolnick P., ed.), Humana, Totowa, NJ, pp. 173-194.
11. Hatanpaa K., Brady D. R., Stoll J., Rapoport S. I., and Chandrasekaran K. (1996) Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 40, 411-420.
12. Heninger G. R., Delgado P. L., and Charney D. S. (1996) The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29, 2-11.
13. Hollister L. E. (1986) Current antidepressants. Ann. Rev. Pharmacol. Toxicol. 26, 23-37.
14. Huang N.-Y., Layer R. T., and Skolnick P. (1997) Is an adaptation of N-methyl-D-aspartate (NMDA) receptors an obligatory step in antidepressant action? in Antidepressants: New Pharmacological Strategies (Skolnick P., ed.), Humana, Totowa, NJ, pp. 125-143.
15. Liang P. and Pardee A. B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967-971.
16. Liang P., Zhu W., Zhang X., Guo Z., O'Connell R. P., Averboukh L., et al. (1994) Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res. 22, 5763-5764.
17. Livesey F. J. and Hunt S. P. (1996) Identifying changes in gene expression in the nervous system: mRNA differential display. TINS 19, 84-88.
18. Nibuya M., Morinobu S., and Duman R. S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539-7547.
19. Nibuya M., Nestler E. J., and Duman R. S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 2365-2372.
20. Nowak G., Li Y., and Paul I. A. (1996) Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. Eur. J. Pharmacol. 295, 75-85.
21. Passero S., Nardini M., and Battistini N. (1995) Regional cerebral blood flow changes following chronic administration of antidepressant drugs. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 19, 627-636.
22. Paul I. A., Nowak G., Layer R. T., Popik P., and Skolnick P. (1994) Adaptation of the N-methyl-D-Aspartate receptor complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther. 269, 95-102.
23. Richelson E. (1994) Pharmacology of antidepressants-characteristics of the ideal drug. Mayo Clin. Proc. 69, 1069-1081.
24. Rossby S. P. and Sulser F. (1997) Antidepressants: beyond the synapse, in Antidepressants: New Pharmacological Strategies (Skolnick P., ed.), Humana, Totowa, NJ, pp. 195-212.
25. Schwaninger M., Schofl C., Blume R., Rossig L., and Knepel W. (1995) Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol. 47, 1112-1118.
26. Shader R. I., Fogelman S. M., and Greenblatt D. J. (1997) Newer antidepressants: further reflections. J. Clin. Psychopharmacol. 17, 75-77.
27. Skolnick P., Layer R. T., Popik P., Nowak G., Paul I. A., and Trullas R. (1996) Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 29, 23-26.
28. Stone E. A. (1983) Problems with the current catecholamine hypothesis of antidepressant agents: speculations leading to a new hypothesis. Behav. Brain Sci. 6, 555-577.
29. Stryer L. (1988) Biochemistry, 3rd ed. W. H. Freeman, New York.
30. Sugrue M. F. (1985) Delayed biochemical changes following antidepressant treatment. Psychopharmacol. Bull. 21, 619-622.
31. Vetulani J. (1991) The development of our understanding of the mechanism of action of antidepressant drugs. Pol. J. Pharmacol. Pharm. 43, 323-338.
32. Vetulani J. and Sulser F. (1975) Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP generating system in limbic forebrain. Nature 257, 495-496.
33. Wang X., Ruffolo R. R. Jr., and Feuerstein G. Z. (1996) mRNA Differential display: application in the discovery of novel pharmacological targets TIPS 17, 276-279.
34. Whatley S. A., Curti D., and Marchbanks R. M. (1996) Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem. Res. 21, 995-1004.
35. Wong M. L., Khatri P., Licinio J., Esposito A., and Gold P. W. (1996) Identification of hypothalamic transcripts upregulated by antidepressants. Biochem. Biophys. Res. Commun. 229, 275-279.
36. Wu H. C. and Lee E. H. Y. (1997) Identification of a rat brain gene associated with aging by PCR differential display method. J. Mol. Neurosci. 8, 13-18.
37. Yakovlev A. G. and Faden A. I. (1995) Molecular strategies in CNS injury. J. Neurotrauma 12, 767-777.
38. Yee F. and Yolken R. H. (1997) Identification of differentially expressed RNA transcripts in neuropsychiatrie disorders. Biol. Psychiatr. 41, 759-761.
39. Zhang H., Zhang R., and Liang P. (1996) Differential screening of gene expression difference enriched by differential display. Nucleic Acids Res. 24, 2454-2455.